Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1992 Jun;38:1467-1468, 1471-1474.

Risks Associated with Treating Hypothyroidism

Potential hazards of L-thyroxine therapy

Hertzel C Gerstein
PMCID: PMC2146155  PMID: 21221404

Abstract

Most patients with hypothyroidism can be treated simply and safely with physiologic replacement dosages of L-thyroxine. Recently, concerns have been raised about potential hazards of L-thyroxine therapy, including a possible increased risk of osteoporosis and ischemic heart disease. The author reviews these concerns and describes a modern approach to initiation and maintenance of thyroid hormone replacement therapy.

Full text

PDF
1467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlin E. V., Maurer A. H., Marks A. D., Channick B. J. Bone mineral density in postmenopausal women treated with L-thyroxine. Am J Med. 1991 Mar;90(3):360–366. doi: 10.1016/0002-9343(91)90577-k. [DOI] [PubMed] [Google Scholar]
  2. Auwerx J., Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Q J Med. 1986 Aug;60(232):737–752. [PubMed] [Google Scholar]
  3. Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev. 1985 Summer;6(3):432–440. doi: 10.1210/edrv-6-3-432. [DOI] [PubMed] [Google Scholar]
  4. Coindre J. M., David J. P., Rivière L., Goussot J. F., Roger P., de Mascarel A., Meunier P. J. Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med. 1986 Jan;146(1):48–53. [PubMed] [Google Scholar]
  5. Cooper D. S., Halpern R., Wood L. C., Levin A. A., Ridgway E. C. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med. 1984 Jul;101(1):18–24. doi: 10.7326/0003-4819-101-1-18. [DOI] [PubMed] [Google Scholar]
  6. Crowley W. F., Jr, Ridgway E. C., Bough E. W., Francis G. S., Daniels G. H., Kourides I. A., Myers G. S., Maloof F. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977 Jan 6;296(1):1–6. doi: 10.1056/NEJM197701062960101. [DOI] [PubMed] [Google Scholar]
  7. Diamond T., Nery L., Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab. 1991 Jun;72(6):1184–1188. doi: 10.1210/jcem-72-6-1184. [DOI] [PubMed] [Google Scholar]
  8. Ettinger B., Wingerd J. Thyroid supplements: effect on bone mass. West J Med. 1982 Jun;136(6):473–476. [PMC free article] [PubMed] [Google Scholar]
  9. Fish L. H., Schwartz H. L., Cavanaugh J., Steffes M. W., Bantle J. P., Oppenheimer J. H. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987 Mar 26;316(13):764–770. doi: 10.1056/NEJM198703263161302. [DOI] [PubMed] [Google Scholar]
  10. Gerstein H. C. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med. 1990 Jul;150(7):1397–1400. [PubMed] [Google Scholar]
  11. Krølner B., Jørgensen J. V., Nielsen S. P. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol (Oxf) 1983 May;18(5):439–446. doi: 10.1111/j.1365-2265.1983.tb02873.x. [DOI] [PubMed] [Google Scholar]
  12. Ladenson P. W., Levin A. A., Ridgway E. C., Daniels G. H. Complications of surgery in hypothyroid patients. Am J Med. 1984 Aug;77(2):261–266. doi: 10.1016/0002-9343(84)90701-0. [DOI] [PubMed] [Google Scholar]
  13. Linde J., Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta Endocrinol (Copenh) 1979 Jul;91(3):437–448. doi: 10.1530/acta.0.0910437. [DOI] [PubMed] [Google Scholar]
  14. Mosekilde L., Melsen F. Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand A. 1978 Jan;86(1):56–62. doi: 10.1111/j.1699-0463.1978.tb02012.x. [DOI] [PubMed] [Google Scholar]
  15. Mundy G. R., Shapiro J. L., Bandelin J. G., Canalis E. M., Raisz L. G. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest. 1976 Sep;58(3):529–534. doi: 10.1172/JCI108497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Myerowitz P. D., Kamienski R. W., Swanson D. K., Chopra P. S., Berkoff H. A., Kroncke G. M., Rowe G. G., Vander Ark C. R., Dhanani S. P. Diagnosis and management of the hypothyroid patient with chest pain. J Thorac Cardiovasc Surg. 1983 Jul;86(1):57–60. [PubMed] [Google Scholar]
  17. Nicoloff J. T., Spencer C. A. Clinical review 12: The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab. 1990 Sep;71(3):553–558. doi: 10.1210/jcem-71-3-553. [DOI] [PubMed] [Google Scholar]
  18. Paul T. L., Kerrigan J., Kelly A. M., Braverman L. E., Baran D. T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988 Jun 3;259(21):3137–3141. [PubMed] [Google Scholar]
  19. Petersen K., Bengtsson C., Lapidus L., Lindstedt G., Nyström E. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med. 1990 Oct;150(10):2077–2081. [PubMed] [Google Scholar]
  20. Ribot C., Tremollieres F., Pouilles J. M., Louvet J. P. Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 1990 Aug;33(2):143–153. doi: 10.1111/j.1365-2265.1990.tb00477.x. [DOI] [PubMed] [Google Scholar]
  21. Robuschi G., Safran M., Braverman L. E., Gnudi A., Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987 May;8(2):142–153. doi: 10.1210/edrv-8-2-142. [DOI] [PubMed] [Google Scholar]
  22. Ross D. S., Neer R. M., Ridgway E. C., Daniels G. H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 1987 Jun;82(6):1167–1170. doi: 10.1016/0002-9343(87)90219-1. [DOI] [PubMed] [Google Scholar]
  23. Singer P. A. Thyroiditis. Acute, subacute, and chronic. Med Clin North Am. 1991 Jan;75(1):61–77. doi: 10.1016/s0025-7125(16)30472-2. [DOI] [PubMed] [Google Scholar]
  24. Stall G. M., Harris S., Sokoll L. J., Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990 Aug 15;113(4):265–269. doi: 10.7326/0003-4819-113-4-265. [DOI] [PubMed] [Google Scholar]
  25. Surks M. I., Chopra I. J., Mariash C. N., Nicoloff J. T., Solomon D. H. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 1990 Mar 16;263(11):1529–1532. [PubMed] [Google Scholar]
  26. Toh S. H., Brown P. H. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J Bone Miner Res. 1990 May;5(5):463–467. doi: 10.1002/jbmr.5650050507. [DOI] [PubMed] [Google Scholar]
  27. Toh S. H., Claunch B. C., Brown P. H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med. 1985 May;145(5):883–886. [PubMed] [Google Scholar]
  28. Tunbridge W. M., Brewis M., French J. M., Appleton D., Bird T., Clark F., Evered D. C., Evans J. G., Hall R., Smith P. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):258–262. doi: 10.1136/bmj.282.6260.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tunbridge W. M., Evered D. C., Hall R., Appleton D., Brewis M., Clark F., Evans J. G., Young E., Bird T., Smith P. A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 Dec;7(6):481–493. doi: 10.1111/j.1365-2265.1977.tb01340.x. [DOI] [PubMed] [Google Scholar]
  30. Weinberg A. D., Brennan M. D., Gorman C. A., Marsh H. M., O'Fallon W. M. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med. 1983 May;143(5):893–897. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES